These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3366566)

  • 21. The role of Igh-1 disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis.
    Akova YA; Dutt J; Rodriguez A; Jabbur N; Foster CS
    Curr Eye Res; 1993 Dec; 12(12):1093-101. PubMed ID: 7907969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence.
    Grau DR; Visalli RJ; Brandt CR
    Invest Ophthalmol Vis Sci; 1989 Dec; 30(12):2474-80. PubMed ID: 2556353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistopathologic findings in herpes simplex virus chorioretinitis in the von Szily model.
    Zaltas MM; Opremcak EM; Hemady R; Foster CS
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):68-77. PubMed ID: 1309731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganglionic permissivity to HSV-1 replication and acyclovir-induced latency: an in vitro model.
    Millin JA; Opremcak EM; Wells PA; Foster CS
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):232-8. PubMed ID: 2828264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.
    Jayaraman S; Heiligenhaus A; Rodriguez A; Soukiasian S; Dorf ME; Foster CS
    J Immunol; 1993 Nov; 151(10):5777-89. PubMed ID: 8228262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes simplex keratitis.
    Kaye S; Choudhary A
    Prog Retin Eye Res; 2006 Jul; 25(4):355-80. PubMed ID: 16807055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.
    Jones CA; Taylor TJ; Knipe DM
    Virology; 2000 Dec; 278(1):137-50. PubMed ID: 11112490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic studies on murine susceptibility to herpes simplex keratitis.
    Foster CS; Tsai Y; Monroe JG; Campbell R; Cestari M; Wetzig R; Knipe D; Greene MI
    Clin Immunol Immunopathol; 1986 Aug; 40(2):313-25. PubMed ID: 3013475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency.
    Gordon YJ; Araullo-Cruz TP; Romanowski E; Ruziczka L; Balouris C; Oren J; Cheng KP; Kim S
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1230-4. PubMed ID: 3015823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.
    Heiligenhaus A; Bauer D; Meller D; Steuhl KP; Tseng SC
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1969-74. PubMed ID: 11481259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
    Alché LE; Berra A; Veloso MJ; Coto CE
    J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of herpes simplex virus type-1 latency in corneas.
    Xie LX; Dong XG; Kaufman HE
    Chin Med J (Engl); 1993 Apr; 106(4):288-91. PubMed ID: 8391970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
    Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A herpes simplex type 1 ICPO deletion mutant demonstrates diminished pathogenicity during acute ocular infection in different host animals.
    Gordon YJ; Romanowski E; Balouris C; Araullo-Cruz T
    Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):681-8. PubMed ID: 2159449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of polymerase chain reaction for quick assay of herpes simplex viral acute ocular infection and ganglionic latent infection].
    Fan J; Zhang WH; Wu YY
    Zhonghua Yan Ke Za Zhi; 1994 Jul; 30(4):298-300. PubMed ID: 7843025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of T cell receptor V beta gene expression in B cell deficient mice after experimental herpes simplex virus keratitis.
    Arrunategui-Correa V; Dutt JE; Foster CS
    Acta Virol; 1997 Jun; 41(3):145-52. PubMed ID: 9385402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of IgH V-region genes on the growth kinetics of a murine B cell leukemia (BCL1).
    Ciavarra R; Forman J
    J Immunol; 1981 Jan; 126(1):54-8. PubMed ID: 6778917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
    Nguyen QD; Uy HS; Merchant A; Medina CA; Baltatzis S; Zhao T; Zhao ZS; Cantor H; Foster CS
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2505-9. PubMed ID: 11581190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.